Evidence map›Paper›PMID 31495594›Full record

ArticleVaccine2019

Analysis of the profitability of adult vaccination in 13 private provider practices in the United States.

Benjamin Yarnoff, Olga Khavjou, Grant King, Laurel Bates, Fangjun Zhou, Andrew J Leidner, Angela K Shen

Open access · greenAbstract read
In one paragraph

Article in Vaccine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.1field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Benjamin YarnoffRTI International, Research Triangle Park, NC, United States. Electronic address: byarnoff@rti.org.
Olga KhavjouRTI International, Research Triangle Park, NC, United States.
Grant KingRTI International, Research Triangle Park, NC, United States.
Laurel BatesRTI International, Research Triangle Park, NC, United States.
Fangjun ZhouNational Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, United States.
Andrew J LeidnerBerry Technology Solutions, Atlanta, GA, United States.
Angela K ShenNational Vaccine Program Office, Office of the Assistant Secretary for Health, US Department of Health and Human Services, Washington, DC, United States.
RTI International · USBerry (United States) · USCenters for Disease Control and Prevention · USOffice of the Assistant Secretary for Health · US

Funding

Intramural CDC HHS CC999999
6 · The paper itself

Abstract

Vaccination coverage among adults remains low in the United States. Understanding the barriers to provision of adult vaccination is an important step to increasing vaccination coverage and improving public health. To better understand financial factors that may affect practice decisions about adult vaccination, this study sought to understand how costs compared with payments for adult vaccinations in a sample of U.S. physician practices. We recruited a convenience sample of 19 practices in nine states in 2017. We conducted a time-motion study to assess the time costs of vaccination activities and conducted a survey of practice managers to assess materials, management, and dose costs and payments for vaccination. We received complete cost and payment data from 13 of the 19 practices. We calculated annual income from vaccination services by comparing estimated costs with payments received for vaccine doses and vaccine administration. Median annual total income from vaccination services was $90,343 at family medicine practices (range: $3968-$249,628), $28,267 at internal medicine practices (-$32,659-$141,034) and $2886 at obstetrics and gynecology practices (-$73,451-$23,820). Adult vaccination was profitable at the median of our sample, but there is wide variation in profitability due to differences in costs and payment rates across practices. This study provides evidence on the financial viability of adult vaccination and supports actions for improving financial viability. These results can help inform practices' decisions whether to provide adult vaccines and contribute to keeping adults up-to-date with the recommended vaccination schedule.

Indexed as

AdultCosts and Cost AnalysisFemaleHealth Care CostsHumansIncomeInternal MedicineMedicaidMedicareObstetricsPrivate PracticeUnited StatesVaccinationVaccinesVaccinesAdult vaccinationBarriers to vaccinationEconomic analysisFinancial analysis

Identifiers

PMID31495594
PMCPMC6778689
OpenAlexW2972025051

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.